Solta Medical Reports Third Quarter 20...($(4194) $735 $(2438) $3383...),Health

Date:11/3/2009

$(4,194) $735 $(2,438) $3,383 ======= ==== ======= ====== GAAP basic net loss per share $(0.13) $(0.05) $(0.23) $(0.06) Non-GAAP adjustments to basic income (loss) per share: Purchase price related charges 0.03 - 0.12 - Severance expenses - - - - Merger-related costs - $0.01 - 0.05 Loss on investments - $0.03 - 0.03 Stock-based compensation 0.02 $0.04 0.06 0.12 ---- ----- ---- ---- Non-GAAP basic net income (loss) per share $(0.09) $0.03 $(0.05) $0.14 ====== ===== ====== ===== Non-GAAP diluted net income (loss) per share $(0.09) $0.03 $(0.05) $0.14 ====== ===== ====== ===== GAAP weighted average shares outstanding used in calculating basic net loss per share 47,855,428 24,067,548 47,807,180 23,861,079 ========== ========== ========== ========== GAAP weighted average shares outstanding used in calculating diluted net loss per share 47,855,428 24,067,548 47,807,180 23,861,079 Adjustments for dilutive potential common stock - 838,410 - 1,057,632 --- ------- --- --------- Weighted average shares outstanding used in calculating non-GAAP diluted net income (loss) per share 47,855,428 24,905,958 47,807,180 24,918,711 ========== ========== ========== ==========

                      
'/>"/>
SOURCE  Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 
Related medicine news :

1. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
2. Solta Medical to Present at the Maxim Group Growth Conference
3. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
4. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
5. Solta Medical Reports Strong Second Quarter 2009 Results
6. Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
7. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
8. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
11. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting